Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
08 Julio 2021 - 2:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: April 2021
Commission File Number: 000-51848
Avricore Health Inc.
(Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
3500 – 1055 Dunsmuir Street PO Box 49114 Vancouver BC V7X1H7
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F x Form 40-F o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes o No x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes o No x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No x
Exhibits
The following exhibits are included in this Form 6-K:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: July 7, 2021
|
AVRICORE HEALTH INC.
|
|
|
|
By: /s/ Kiki Smith
|
|
Kiki Smith
|
|
Chief Financial Officer
|
2
Avricore Health (QB) (USOTC:AVCRF)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Avricore Health (QB) (USOTC:AVCRF)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Avricore Health Inc (QB) (OTCMarkets): 0 recent articles
Más de Avricore Health Inc. Artículos de Noticias